Actylis Acquires Pharm-RX
October 2024
Actylis has acquired Pharm-Rx, a leading distributor of specialty ingredients for the vitamin, mineral, supplement (VMS), and pharmaceutical industries. This acquisition strengthens Actylis' portfolio and positions it to deliver more innovative solutions to its customers, expanding its reach and expertise in the growing nutrition and OTC pharmaceutical markets. Pharm-Rx’s team will join Actylis to drive accelerated growth.
Technical paper brought to you by Actylis.
Supplements
Isovalerate might be key to improving malnutrition in children, mouse study reveals
A mouse study has discovered that a cost-effective supplemental intervention could potentially help improve the health outcomes of children with malnutrition. It highlights the role of the microbial metabolite isovalerate in...
Supplements
Oral delivery blurs the line between supplement and gray-market peptides
The emerging peptide market is rapidly growing, and so too are concerns about the safety of these short chains of amino acids as consumers and industries grapple with distinguishing them from supplements. The labels on these...
Supplements
MIT electrodes extract magnesium from seawater at low cost and high concentration
An American Chemical Society (ACS) study has developed a new way of extracting magnesium from seawater using electricity, which is typically derived from energy-intensive methods of crushing and heating rocks.
